Drug Pricing

All articles by Drug Pricing

The most and least expensive cities for prescription drugs
The most and least expensive cities for prescription drugs
Lecia Bushak
August 29, 2022
3:04 pm

A GoodRx report finds that Lexington and Little Rock have overtaken San Francisco and Los Angeles for the highest medication costs.

Bluebird’s $2.8M gene therapy opens door to pricing questions
Bluebird’s $2.8M gene therapy opens door to pricing questions
Marc Iskowitz
August 19, 2022
1:26 pm

Intended as a one-time treatment for a rare blood disorder, the pricey drug is being launched with an outcomes-based deal.

How the Inflation Reduction Act turns up the heat on drug pricing
How the Inflation Reduction Act turns up the heat on drug pricing
Marc Iskowitz
August 18, 2022
3:32 pm

Launch optimizing, unique rebating and extra advertising: 3 takeaways for pharma marketers.

More ‘games’ in store? Drugmakers ponder response to Medicare price controls
More ‘games’ in store? Drugmakers ponder response to Medicare price controls
Marc Iskowitz
August 9, 2022
4:06 pm

Potential countermeasures could range from higher launch prices to authorized generics.

After years of debate, drug pricing regulation’s day arrives
After years of debate, drug pricing regulation’s day arrives
Lecia Bushak
August 8, 2022
5:28 pm

The impact of the Inflation Reduction Act on pharma, however, is likely to be limited for now.

GoodRx among most Googled coupons in America
GoodRx among most Googled coupons in America
Jack O'Brien
July 18, 2022
3:42 pm

The prescription drug company had the most Googled coupons in eight states.

Congress turns its attention to drug pricing regulation. Again.
Congress turns its attention to drug pricing regulation. Again.
Lecia Bushak
July 14, 2022
3:14 pm

After the most recent pricing proposal died last year with the Build Back Better bill, lawmakers are aiming to revive it.

Amylyx’s ALS drug would not be cost-effective if priced like another ALS drug on the market
Amylyx’s ALS drug would not be cost-effective if priced like another ALS drug on the market
Marc Iskowitz
June 14, 2022
2:42 pm

The pricing watchdog ICER believes policymakers should debate short-term pricing options until the drug’s benefits can be ascertained.

Patients for Affordable Drugs gets back on the air
Patients for Affordable Drugs gets back on the air
Lecia Bushak
May 4, 2022
1:50 pm

The campaign is designed to reignite the push for Congress to lower drug prices.

Building a better Build Back Better
Building a better Build Back Better
Lecia Bushak
January 27, 2022
3:01 pm

As Democrats seek to revive Build Back Better, drug pricing reform tops the list of provisions likely to make the final cut.

  • From Our Partners